iCAD introduces products, lease

Article

In a flurry of activity, iCAD of Hudson, NH, has introduced a new version of its mammography computer-aided detection system, MammoReader II, a leasing program to promote its acquisition, and new CAD software. With two mammographic digitizers and a

In a flurry of activity, iCAD of Hudson, NH, has introduced a new version of its mammography computer-aided detection system, MammoReader II, a leasing program to promote its acquisition, and new CAD software. With two mammographic digitizers and a high-speed, dual-processor computer workstation, MammoReader II can process up to 39 breast cancer screening cases per hour. The new system, which includes an integrated Scanner/Analyzer Workstation with a backlit review panel, is available through Instrumentarium Imaging, the exclusive U.S. distributor for iCAD breast cancer detection products. It can be acquired under a CADLease operating program, which allows reduced payments during the first year of the lease to provide customers time to build revenue from its use. The company has also released a new version of its CAD software that cuts by 25% the time needed to digitize and analyze groups of mammograms. The new release also allows users to automatically print CAD results for distribution and review in hard-copy form.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.